NRPB7L Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
NRPB7L antibody; At4g14520 antibody; dl3300w antibody; DNA-directed RNA polymerase subunit 7-like protein antibody
Target Names
NRPB7L
Uniprot No.

Target Background

Database Links

KEGG: ath:AT4G14520

STRING: 3702.AT4G14520.1

UniGene: At.33272

Protein Families
Eukaryotic RPB7/RPC8 RNA polymerase subunit family
Subcellular Location
Nucleus.

Q&A

What is NRPB7L and why is it significant in plant research?

NRPB7L (Nuclear RNA Polymerase B 7-Like) is a protein in Arabidopsis thaliana that functions as an auxiliary component related to the RNA polymerase II complex. Based on sequence homology and functional analysis, NRPB7L shares characteristics with NRPB7, which is a documented subunit of RNA polymerase II involved in transcription . The significance of NRPB7L lies in its potential role in regulating transcriptional processes in plants, making it an important target for researchers studying gene expression mechanisms in Arabidopsis.

The study of NRPB7L contributes to our understanding of plant-specific transcriptional machinery variations, as RNA polymerase composition in plants can differ from other eukaryotes. Research methodologies typically include gene knockout experiments, protein-protein interaction studies, and transcriptome analysis to determine the specific functions of this protein.

How does NRPB7L differ from standard NRPB7 in structure and function?

While both proteins are related to RNA polymerase II function, NRPB7L represents a variant or paralog of the standard NRPB7 subunit. Based on comparative analysis of transcript data from Arabidopsis tissues, NRPB7 is expressed at levels of approximately 2.0 TPM (Transcripts Per Million) in seedling tissue, while its expression patterns may differ in other tissues or developmental stages .

The functional differences between NRPB7L and NRPB7 likely involve:

  • Tissue-specific or condition-specific expression patterns

  • Differential interaction with other polymerase components

  • Potentially specialized roles in transcription under particular conditions

To investigate these differences methodologically, researchers should employ:

  • Side-by-side protein sequence alignment and structural prediction

  • Comparative expression analysis across tissues and conditions

  • Protein-protein interaction studies to identify unique binding partners

  • Functional complementation tests to determine interchangeability

What applications is the NRPB7L antibody most commonly used for in plant research?

The NRPB7L antibody serves as a valuable tool for several molecular biology techniques in plant research, particularly in Arabidopsis studies. Based on the product information, this antibody has been validated for the following applications :

  • Western blotting (WB) – For detecting NRPB7L protein in plant tissue extracts, allowing quantification and comparison across different samples or conditions

  • ELISA – For quantitative measurement of NRPB7L levels in plant extracts

  • Immunoprecipitation – Though not explicitly validated, similar antibodies are often used for isolating protein complexes containing the target protein

The methodological approach for using this antibody effectively involves careful optimization of protocols specific to plant tissues, including:

  • Proper tissue extraction methods to preserve protein integrity

  • Optimization of antibody dilutions (typically starting at 1:400 dilution for primary antibody incubation)

  • Validation of specificity using appropriate positive and negative controls

How should I validate the specificity of an NRPB7L antibody before using it in my experiments?

Antibody validation is a critical step before using any antibody in research, including NRPB7L antibodies. A comprehensive validation approach includes:

  • Knockout/knockdown control testing: The gold standard validation method involves testing the antibody on samples from NRPB7L knockout or knockdown plants alongside wild-type samples. A specific antibody should show significantly reduced or absent signal in the knockout samples .

  • Western blot analysis: Confirm that the antibody detects a band of the expected molecular weight (~20-25 kDa for NRPB7L). Multiple bands may indicate cross-reactivity with other proteins.

  • Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before using it in your experiment. A specific antibody's signal should be blocked or significantly reduced.

  • Cross-reactivity testing: Especially important for polyclonal antibodies like the commercial NRPB7L antibody, test for cross-reactivity with related proteins such as NRPB7 and other RNA polymerase subunits.

Recent research has shown that many commercial antibodies fail validation tests, with one study finding that only about two-thirds of tested antibodies were effective for their intended targets . Therefore, thorough validation is essential for reliable research outcomes.

What are the optimal fixation and permeabilization conditions for immunolocalization of NRPB7L in plant tissues?

For successful immunolocalization of NRPB7L in Arabidopsis tissues, consider the following methodological approach:

  • Fixation: Use 4% paraformaldehyde in PBS for 20-30 minutes at room temperature. This preserves cellular structure while maintaining protein antigenicity. For higher sensitivity, test both aldehyde-based (paraformaldehyde) and alcohol-based (methanol/ethanol) fixation methods, as different antibodies may perform optimally under different fixation conditions.

  • Permeabilization: After fixation, permeabilize with 0.1-0.5% Triton X-100 in PBS for 10-15 minutes. For plant tissues with cell walls, additional permeabilization may be necessary, potentially including:

    • Brief enzymatic digestion with cell wall-degrading enzymes

    • Longer incubation with detergents

    • Use of microwave-assisted techniques to enhance antibody penetration

  • Blocking: Use 3-5% BSA or 5% normal serum from the same species as the secondary antibody in PBG (PBS with 0.2% gelatin) for 30-60 minutes to reduce nonspecific binding .

  • Antibody application: Dilute the NRPB7L antibody in blocking solution (typically 1:400 dilution as a starting point) and incubate overnight at 4°C .

Importantly, plant tissues, especially those with high autofluorescence, may require additional steps such as treatment with sodium borohydride or Sudan Black B to reduce background fluorescence.

How can I quantitatively assess NRPB7L expression levels across different plant tissues and developmental stages?

Quantitative assessment of NRPB7L expression requires a multi-method approach for comprehensive analysis:

  • Transcript level analysis:

    • qRT-PCR targeting NRPB7L mRNA with carefully validated primers

    • RNA-seq analysis of different tissues, with data processing similar to the methods used in the analysis showing differential expression between sperm (1.1 TPM) and seedling (2.0 TPM) for the related NRPB7

  • Protein level analysis:

    • Western blot with the NRPB7L antibody, using equal protein loading confirmed by housekeeping proteins

    • Quantitative ELISA assays, which this antibody has been validated for

  • Spatial expression patterns:

    • Immunolocalization in different tissues using confocal microscopy

    • Comparison of nuclear vs. cytoplasmic distribution using nuclear markers like H2B-mRuby

For quantitative immunolocalization, follow a method similar to that described for RNA polymerase II detection in Arabidopsis pollen:

  • Acquire Z-stack images using confocal microscopy

  • Compile projections using Fiji's Z project function

  • Measure nuclear intensity in manually selected regions

  • Calculate the ratio of NRPB7L signal to a nuclear marker like H2B

Present the data as a comprehensive table showing expression levels across tissues:

Tissue TypemRNA Expression (qRT-PCR)Protein Level (Western Blot)Nuclear Localization (Immunofluorescence)
SeedlingReference valueReference valueReference value
LeafRelative to seedlingRelative to seedlingDistribution pattern
RootRelative to seedlingRelative to seedlingDistribution pattern
ReproductiveRelative to seedlingRelative to seedlingDistribution pattern

What are the most common causes of non-specific binding when using NRPB7L antibody, and how can I address them?

Non-specific binding is a common challenge when working with polyclonal antibodies like the NRPB7L antibody. The primary causes and solutions include:

  • Cross-reactivity with related proteins:

    • NRPB7L has sequence similarity with NRPB7 and potentially other RNA polymerase subunits

    • Solution: Pre-absorb the antibody with recombinant related proteins or use more stringent washing conditions

  • Insufficient blocking:

    • Solution: Increase blocking time (2-3 hours), try different blocking agents (BSA, normal serum, commercial blockers), or use a combination of blockers

  • Suboptimal antibody dilution:

    • Solution: Perform a dilution series (1:200 to 1:2000) to identify the optimal concentration that maximizes specific signal while minimizing background

  • Fixation artifacts:

    • Solution: Test alternative fixation methods; some epitopes are sensitive to overfixation

  • Plant-specific issues:

    • Arabidopsis tissues contain compounds that can cause background

    • Solution: Include additional washing steps with high salt buffer (up to 500 mM NaCl) and 0.1% Tween-20

For methodological validation of specificity, consider the criteria used in systematic antibody validation studies, which found that recombinant antibodies generally perform better than polyclonal antibodies for specificity . If persistent problems occur, consider:

  • Using antigen affinity-purified antibody fractions

  • Implementing a more rigorous validation pipeline similar to those described in contemporary antibody characterization studies

  • Including appropriate negative controls (samples without primary antibody) in each experiment

How should I interpret contradictory results between transcript levels and protein detection of NRPB7L?

Discrepancies between transcript levels and protein detection are common in biological research and may reflect genuine biological phenomena rather than technical errors. A methodical approach to interpret such contradictions includes:

  • Verify technical aspects first:

    • Confirm primer specificity for transcript analysis

    • Validate antibody specificity as described in FAQ 2.1

    • Check for sample degradation issues

  • Consider biological explanations:

    • Post-transcriptional regulation: NRPB7L may be subject to miRNA regulation or differential mRNA stability

    • Post-translational regulation: Protein half-life differences across tissues

    • Context-dependent protein expression: Similar to findings in transcriptionally active regions being highly limited in sperm nuclei compared to vegetative nuclei

  • Perform time-course experiments:

    • Track both transcript and protein levels over time to identify temporal relationships

    • Use translation inhibitors (cycloheximide) or proteasome inhibitors (MG132) to assess protein stability

  • Quantitative comparison:

    • Use absolute quantification methods for both transcript (digital PCR) and protein (quantitative Western blotting with recombinant standards)

    • Compare the ratios across different tissues rather than absolute values

Similar discrepancies have been observed in studies of RNA polymerase II subunits in Arabidopsis, where the expression levels of different subunits vary considerably across tissues . For example, the table below shows transcript levels of various RNAPII subunits in sperm vs. seedling:

SubunitSperm (TPM)Seedling (TPM)Log 2(FC+1)
NRPB16.146.50.2
NRPB71.12.00.6
NRPB6a34.730.81.1
NRPB6b137.930.82.5

These variations highlight that protein complex components can be differentially regulated at transcript and protein levels.

How can I use the NRPB7L antibody for chromatin immunoprecipitation (ChIP) experiments to identify DNA-binding sites?

Chromatin immunoprecipitation (ChIP) with NRPB7L antibody requires careful optimization for successful identification of DNA-binding sites. A comprehensive methodological approach includes:

  • Pre-Experimental Validation:

    • Confirm nuclear localization of NRPB7L using immunofluorescence microscopy

    • Verify antibody specificity via Western blot of nuclear extracts

    • Determine optimal formaldehyde crosslinking conditions (typically 1% for 10 minutes at room temperature for plant tissues)

  • ChIP Protocol Optimization:

    • Use a protocol similar to that described for studying RNA polymerase II in Arabidopsis

    • Sonication conditions must be carefully optimized for plant tissues to achieve DNA fragments of 200-500 bp

    • Include appropriate controls:

      • Input DNA (pre-immunoprecipitation)

      • Mock IP (no antibody control)

      • IP with unrelated antibody (e.g., anti-GFP)

      • IP with a known RNA polymerase II subunit antibody for comparison

  • Data Analysis:

    • For ChIP-seq, use analytical pipelines similar to those employed for RNA polymerase II ChIP-seq data

    • For targeted ChIP-qPCR, design primers for housekeeping genes as positive controls and non-transcribed regions as negative controls

  • Integration with Other Data Types:

    • Compare NRPB7L binding profiles with other RNAPII subunits

    • Correlate binding with transcriptional activity data

    • Integrate with histone modification ChIP data to understand chromatin context

For ChIP-seq experiments, consider the approach used in studies of RNA polymerase II occupancy , where transcriptionally active regions were identified using antibodies against phosphorylated RNAPII-CTD. This approach revealed significant differences in transcriptional activity between different cell types (e.g., sperm versus vegetative nuclei) .

What approaches can I use to study NRPB7L interactions with other proteins in the transcription complex?

Understanding NRPB7L's protein-protein interactions within the transcription complex requires a multi-faceted approach:

  • Affinity Purification-Mass Spectrometry (AP-MS):

    • Create transgenic Arabidopsis lines expressing tagged NRPB7L (GS-tag or similar)

    • Perform affinity purification followed by mass spectrometry analysis

    • Compare data with known RNA polymerase II interactomes like those established for NRPB1-GS

    • Expect to identify interactions with core RNAPII subunits and potentially unique NRPB7L partners

  • Co-Immunoprecipitation (Co-IP):

    • Use the NRPB7L antibody for immunoprecipitation from plant extracts

    • Probe Western blots with antibodies against suspected interaction partners

    • Include reciprocal Co-IPs to confirm interactions

  • Yeast Two-Hybrid (Y2H) or Split-Ubiquitin Assays:

    • Test direct interactions with specific candidates

    • Screen libraries to identify novel interaction partners

  • Bimolecular Fluorescence Complementation (BiFC):

    • Visualize interactions in planta

    • Determine subcellular localization of interaction complexes

When analyzing data, reference the comprehensive RNA polymerase II interactome data available for Arabidopsis . The table below summarizes key proteins found interacting with RNA polymerase II subunits that could be potential NRPB7L interactors:

Protein/ComplexFunctionDetected with RNA Pol II subunitsReference
TFIIF (RAP74/RAP30)Transcription initiationNRPB1
TFIISTranscription elongationNRPB1
SPT5Transcript elongationNRPB1
PAF1-C (ELF7, CDC73)Transcription regulationMultiple NRPB subunits
FACT (SSRP1, SPT16)Chromatin remodelingMultiple NRPB subunits

How can I design experiments to distinguish the specific roles of NRPB7L from the canonical NRPB7 in transcription regulation?

Distinguishing the specific roles of NRPB7L from NRPB7 requires sophisticated experimental approaches that isolate their individual functions:

  • Genetic Approaches:

    • Generate single and double knockout/knockdown lines (T-DNA insertion, CRISPR/Cas9, or RNAi)

    • Create complementation lines where NRPB7L knockout is rescued with:

      • Wild-type NRPB7L

      • NRPB7

      • Chimeric proteins combining domains from both

    • Analyze phenotypes, transcriptomes, and stress responses

  • Domain Swap Experiments:

    • Identify unique domains/regions in NRPB7L through bioinformatic analysis

    • Create chimeric proteins with domains exchanged between NRPB7L and NRPB7

    • Express in knockout backgrounds and assess functional complementation

  • Differential Interactome Analysis:

    • Perform parallel AP-MS experiments with tagged NRPB7L and NRPB7

    • Compare interacting partners to identify unique vs. shared interaction networks

    • Focus on condition-dependent interactions (stress, developmental stages)

  • Genomic Occupancy Comparison:

    • Perform ChIP-seq with NRPB7L and NRPB7 antibodies under identical conditions

    • Identify unique and shared binding sites genome-wide

    • Correlate binding with gene expression data to infer functional significance

  • Targeted Mutagenesis:

    • Identify key residues that differ between NRPB7L and NRPB7

    • Create point mutations at these positions and assess functional consequences

    • Use structural prediction to understand the mechanistic basis of functional differences

For data interpretation, build on observations from RNA polymerase II complex studies in Arabidopsis , where different subunits and isoforms show tissue-specific expression patterns and potentially specialized functions . Consider that the expression pattern of NRPB7 already shows tissue-specificity (higher in seedling than in sperm cells), suggesting that NRPB7L may have evolved for function in specific cell types or conditions.

How might NRPB7L antibodies be used to study transcriptional regulation under stress conditions in plants?

NRPB7L antibodies offer powerful tools for investigating stress-responsive transcriptional regulation in plants:

  • Stress-Induced Relocalization Studies:

    • Track NRPB7L nuclear distribution patterns before and after exposure to various stresses (drought, salt, heat, pathogen)

    • Use immunofluorescence microscopy or live-cell imaging with fluorescent tags

    • Compare with distribution patterns of canonical NRPB7 to identify differential responses

  • Stress-Dependent Protein Complex Remodeling:

    • Perform immunoprecipitation of NRPB7L under normal and stress conditions

    • Use mass spectrometry to identify stress-specific interaction partners

    • Focus on proteins known to be involved in stress-responsive transcription

  • Genome-Wide Occupancy Shifts:

    • Conduct ChIP-seq experiments comparing NRPB7L binding profiles under normal and stress conditions

    • Identify genes where NRPB7L occupancy changes significantly during stress

    • Correlate with transcriptional changes and chromatin state alterations

  • Post-Translational Modifications (PTMs):

    • Use the antibody to immunoprecipitate NRPB7L from stress-treated tissues

    • Perform mass spectrometry to identify stress-induced PTMs

    • Generate modification-specific antibodies for key PTMs to track their dynamics

This research could build on findings regarding RNA polymerase II in plants under stress conditions and potentially reveal specialized roles for NRPB7L in adapting transcriptional responses to environmental challenges.

What new technologies or approaches might enhance the specificity and applications of NRPB7L antibodies in the future?

Emerging technologies promise to revolutionize antibody development and applications for research targets like NRPB7L:

  • Recombinant Antibody Technology:

    • Development of recombinant NRPB7L antibodies could significantly improve specificity, as recombinant antibodies have demonstrated superior performance compared to polyclonal antibodies

    • Single-chain variable fragments (scFvs) or nanobodies specific to NRPB7L could provide better access to crowded nuclear environments

    • The success rate of recombinant antibodies could be enhanced using technologies similar to those described for nanobody design against SARS-CoV-2 variants

  • AI-Assisted Antibody Design:

    • Computational tools like those described in "The Virtual Lab" could design NRPB7L-specific nanobodies with optimized binding properties

    • The integration of protein language models (ESM), protein folding models (AlphaFold-Multimer), and computational biology software (Rosetta) could revolutionize antibody design

    • Atomically accurate de novo design approaches using RFdiffusion could create antibodies with unprecedented specificity

  • Epitope-Specific Approaches:

    • Development of antibodies targeting unique epitopes that distinguish NRPB7L from NRPB7

    • Implementation of epitope mapping techniques to identify the most specific regions for antibody generation

    • Creation of a panel of antibodies recognizing different epitopes to provide comprehensive coverage of the protein

  • Enhancing Validation Pipelines:

    • Implementation of standardized validation pipelines similar to those described for commercial antibodies

    • Development of Arabidopsis cell lines with NRPB7L knockouts as definitive negative controls

    • Creation of comprehensive databases documenting antibody validation results, similar to antibody structure databases like AbDb

As these technologies develop, they will enable more precise and versatile applications of NRPB7L antibodies in plant research, potentially facilitating discoveries about specialized roles of this protein in transcriptional regulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.